Ventricular Assist Device Market is Driven by Rising Incidence of Cardiovascular Diseases

1
Product Type - Left Ventricular Assist Device
(LVAD), Right Ventricular Assist Device (RVAD),
Bi-Ventricular Assist Device (Bi-VAD), and Total
Artificial Heart (TAH) Indication - Bridge To
Transplant (BTT), Destination Therapy (DT), and
Bridge To Recovery(BTR)- Forecast 2016-2024
Ventricular Assist Device Market
2
Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary North America Ventricular Assist Device Market
Chapter 4 Market Overview
Chapter 5 North America Ventricular Assist Device Market Analysis and Forecast, By Product Type
Chapter 6 North America Ventricular Assist Device Market Analysis and Forecast, By Indication
Chapter 7 North America Ventricular Assist Device Market Analysis and Forecast, By Region
Chapter 8 U.S. Ventricular Assist Device Market Analysis and Forecast 
Chapter 9 Canada Ventricular Assist Device Market Analysis and Forecast 
Chapter 10 Competition Landscape
3
Ventricular Assist Device Market Snapshot

• Advance Heart Failure is characterized as
  weakening of the heart caused due to failure of
  the left ventricle, due to which the heart is
  unable to pump blood to different parts of the
  body. According to the AHA (American Heart
  Association), 5.7 Mn people in the U.S suffer
  from heart failure and 300,000 die each year of
  heart failure. 
• The demand within the global market for
  ventricular assist devices has been escalating at
  a stellar pace, majorly due to advancements in
  the medical fraternity.
• Market related factors such as technological
  developments, patent expiry, recent approvals,
  investment in clinical studies and acquisitions
  by leading players in the market, and historical
  year-on-year growth have been taken into
  consideration while estimating the market size. 

4
(No Transcript)
5
Reports Highlights

• The North America Market for ventricular Assist
  Devices offered an opportunity worth US0.49 bn
  in 2015. Expanding at an impressive CAGR of 9.20
  during the period from 2016 to 2024, the market
  is projected to reach US1.07 bn by 2024.
• The demand within the global market for
  ventricular assist devices has been escalating at
  a stellar pace, majorly due to advancements in
  the medical fraternity. The healthcare industry
  has become open to the induction of new
  technologies that can assist medical
  practitioners and specialists during treatment. 
• The number of annual patients hosted by
  healthcare centers and hospitals has been rising
  at a stellar rate in recent times. This has in
  turn generated huge-scale revenues for the
  healthcare industry. An increase in the revenue
  base of hospitals allows them to install seamless
  technologies. 

Request Sample
6
(No Transcript)